Ignite Creation Date:
2024-07-17 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06478472
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-06-23
Brief Title:
Prospective Clinical Study of Orelabrutinib in Combination With Rituximab OR for Primary Marginal Zone Lymphoma MZL That Failed or Not Suitable for Local Therapy
Sponsor:
The First Affiliated Hospital of Xiamen University
Organization:
The First Affiliated Hospital of Xiamen University
Organization Data
Organization:
The First Affiliated Hospital of Xiamen University
Class:
OTHER
Study ID:
XMDYYYXYK-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Affiliated Hospital of Xiamen University
Lead Sponsor Class:
OTHER
Responsible Party:
Bing Xu
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The First Affiliated Hospital of Xiamen University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The First Hospital of Jilin University | OTHER |
| Fujian Cancer Hospital | OTHER_GOV |
| Guangdong Provincial Peoples Hospital | OTHER |
| Nanfang Hospital Southern Medical University | OTHER |
| The Second Affiliated Hospital of Dalian Medical University | OTHER |
| Jiangxi Provincial Cancer Hospital | OTHER |
| Wuhan Union Hospital China | OTHER |
| Shanxi Provincial Cancer Hospital | OTHER |
| Chinese PLA General Hospital | OTHER |